Radical Lung Radiotherapy Plus Nelfinavir

NCT01447589 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped failed to recruit, no suitable patients

Conditions

Lung Cancer

Interventions

DRUG: nelfinavir
RADIATION: Radical Radiotherapy

Sponsor

Oxford University Hospitals NHS Trust